Identifying Biomarkers of Spinal Muscular Atrophy for Further Development

Abstract

NF is a promising SMA biomarker with the potential for prognostic, predictive, and pharmacodynamic capabilities. The Working Group has identified needed information to continue efforts toward the validation of NF as a biomarker for SMA.